NuVasive (GMED) Long-Term Liabilities to Equity

Globus Medical, Inc. (GMED) strives for global dominance in orthopedics, actively implementing robotics following a major merger. The brand's high status among physicians is driven by advanced implants that restore health. The current figure is 0.02. The price trend reflected below confirms the resilience of the business, which generates revenue from the production of spinal instruments, relying on an extensive network of plants to maintain high margins.

To minimize risks when establishing a long-term position, it is essential to evaluate the ratio of loans with maturities exceeding one year to equity, which determines the company's degree of dependence on borrowed funds. By analyzing the trend of the long-term debt-to-equity ratio, an investor can see how the predictability of insurance reimbursement revenues in the spinal surgery sector provides Globus Medical, Inc. (GMED) with business stability for debt servicing.